Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

For RFK Jr. and his antivax supporters and associates, aluminum adjuvants in some required children’s vaccines appear to be ...

Novo Nordisk ( ($NVO) ) has risen by 10.44%. Read on to learn why. Novo Nordisk has seen a notable 10.44% increase in its stock price over the ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...

(Reuters) -West Pharmaceutical raised its annual profit forecast and trimmed its estimates for tariff impact on Thursday, sending the medical equipment maker's shares up 24% in early trading. West ...

The 68-year-old former two-term governor, four-term attorney general and 14-year state lawmaker indicated Saturday night he ...

Roy Cooper will lead the North Carolina Democrats’ effort to win a U.S. Senate election for the first time since 2008.

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...